Results 91 to 100 of about 76,145 (237)

Perspectives of Healthcare Professionals, Patients and Family Members on Managing Regular Medications Across the Perioperative Pathway: An Exploratory Qualitative Study

open access: yesJournal of Advanced Nursing, EarlyView.
ABSTRACT Aim To explore healthcare professionals', patients', and family members' experiences of managing regular medications across the perioperative pathway in a specialist cancer hospital in Melbourne. Design An exploratory qualitative study using a descriptive‐interpretive approach.
Atefeh Mehrabifar   +5 more
wiley   +1 more source

Comparing ceftolozane/tazobactam versus piperacillin/tazobactam as empiric therapy for complicated urinary tract infection in Taiwan: A cost-utility model focusing on gram-negative bacteria

open access: yesJournal of Microbiology, Immunology and Infection, 2019
Background: Complicated urinary tract infection (cUTI) is often associated with drug-resistant pathogens and requires therapy with broad-spectrum antibiotics.
Guan-Jhou Chen   +5 more
doaj   +1 more source

Development of acute kidney injury with concomitant use of Vancomycin and Piperacillin-Tasobactam : A review of recent literature [PDF]

open access: yes, 2017
This article explores the potential association between co-administration of vancomycin and piperacillin-tazobactam with the development of acute kidney injury (AKI) when compared with vancomycin and other beta lactam antibiotics or vancomycin ...
Gruss, Jason   +3 more
core   +1 more source

Research Progress on Risk Factors for Acute Kidney Injury After Antibiotic‐Loaded Bone Cement Spacer Treatment for Periprosthetic Joint Infection

open access: yesOrthopaedic Surgery, EarlyView.
During the two‐stage revision treatment of PJI patients, the use of ALCS may lead to the development of AKI, which could result in severe adverse outcomes. Despite the wide variation in the incidence of developing AKI reported in the literature, clinicians still need adequate attention, especially when confronting PJI patients who are elderly, obese ...
Lijun Cai   +6 more
wiley   +1 more source

Adverse Event Signals Associated with Beta-Lactamase Inhibitors: Disproportionality Analysis of USFDA Adverse Event Reporting System

open access: yesJournal of Xenobiotics
Background: Beta-lactamase inhibitors (BLIs) are widely used with beta-lactam antibiotics to combat resistant infections, yet their safety profiles, especially for newer agents, remain underexplored.
Kannan Sridharan, Gowri Sivaramakrishnan
doaj   +1 more source

Anton’s syndrome [PDF]

open access: yes, 2013
57-year-old male admitted to ITU with a severe Community Acquired Pneumonia. Stayed in ITU for about three weeks and during this period suffered an episode of deterioration which was attributed to multiple venous infarcts of the brain.
Portelli, Luke
core  

Etiology, pathogenesis and treatment of peri‐implantitis: A European perspective

open access: yesPeriodontology 2000, EarlyView.
Abstract Peri‐implantitis is a plaque‐associated pathological condition occurring in tissues around dental implants. It is characterized by inflammation in the peri‐implant mucosa and progressive loss of supporting bone. Over the last 30 years, peri‐implantitis has become a major disease burden in dentistry.
Tord Berglundh   +3 more
wiley   +1 more source

Population Pharmacokinetic Modeling of Piperacillin/Tazobactam in Healthy Adults and Exploration of Optimal Dosing Strategies

open access: yesPharmaceuticals
Background/Objectives: Current dosing recommendations for piperacillin/tazobactam suggest adjustments only for patients with creatinine clearance (CrCl) below 40 mL/min, potentially neglecting the variability in drug exposure among patients with a CrCl ...
Yun Jung Lee   +3 more
doaj   +1 more source

Mystery and misery of locally‐delivered drug therapy in periodontics. Historical concepts and current state

open access: yesPeriodontology 2000, EarlyView.
Abstract The primary objective is to critically analyze approaches to local therapy for periodontal disease, particularly in light of its well‐established systemic implications. We specifically address common misconceptions and overestimations regarding the potential of local treatments in contrast to their actual clinical effectiveness.
Andrea Mombelli, Alkisti Zekeridou
wiley   +1 more source

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

open access: yesBrazilian Journal of Infectious Diseases, 2017
This study evaluated the in vitro activity of ceftolozane-tazobactam and comparator agents tested against Latin American isolates of Enterobacteriaceae and Pseudomonas aeruginosa from patients with health care-associated infections.
Michael A. Pfaller   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy